18th June 2021
The PSA test is not specific to prostate cancer and can be affected by many factors. Many patients request a test, but it is important that they are aware of the pros and cons of the test. It may be useful to consider the following when discussing a PSA test with a patient.
- Ethnicity- black men have an increased risk of prostate cancer
- Pre-existing comorbidities
- Findings from a digital rectal examination (DRE)
GatewayC’s ‘Prostate Cancer – Responding to a PSA Screening Request’ course aims to support health practitioners to have conversations regarding the pros and cons of PSA testing with asymptomatic patients.
Find out more:
- Access GatewayC’s ‘Prostate Cancer – Responding to a PSA Screening Request’ course here
- Read PHE’s 2020 guidance on ‘Advising well men about the PSA test for prostate cancer: information for GPs’ here
- Read NHS England’s 2018 report on ‘Implementing a timed prostate cancer diagnostic pathway’ here